LIFE360 INC (360)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

360 - LIFE360 INC

FNArena Sector : Software & Services

Year End: December

GICS Industry Group : Software & Services

Debt/EBITDA: 0.34

Index: ASX100 | ASX200 | ASX300 | ALL-ORDS | ALL-TECH

Life360 Inc is a San Francisco based software technology company providing real time location sharing apps which allow users to view their contact's location and communicate with them. The company listed on the ASX in 2019.

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$20.72 27 Mar 2025	-0.670 OPEN $20.98	-3.13% HIGH $21.00	1,001,767 LOW $20.37

TARGET

$27.16

31.1% upside

Franking for last dividend paid out: 0%

OTHER COMPANIES IN THE SAME SECTOR
AHI . ALC . AMX . ATA . BMT . COS . DOC . EVS . GTK . KYP . NET . NXL . QOR . RDY . SKO . UBN . VGL . XF1 . YOJ . Z2U .

FNARENA'S MARKET CONSENSUS FORECASTS

12 Month Avg FX Values

Present FX Values

Original Currency

Title	FY25 Forecast	FY26 Forecast
EPS (cps)	57.2	xxx
DPS (cps)	0.0	xxx
EPS Growth	N/A	xxx
DPS Growth	N/A	xxx
PE Ratio	36.7	xxx
Dividend Yield	0.0%	xxx
Div Pay Ratio(%)	N/A	xxx

Title	FY25 Forecast	FY26 Forecast
EPS (cps)	59.2	xxx
DPS (cps)	0.0	xxx
EPS Growth	N/A	xxx
DPS Growth	N/A	xxx
PE Ratio	35.4	xxx
Dividend Yield	0.0%	xxx
Div Pay Ratio(%)	N/A	xxx

Title	FY23 Actual	FY24 Actual	FY25 Forecast	FY26 Forecast
EPS (cps)	xxx	N/A	37.3	xxx
DPS (cps)	xxx	N/A	0.0	xxx
EPS Growth	xxx	N/A	N/A	xxx
DPS Growth	xxx	N/A	N/A	xxx
Div Pay Ratio(%)	xxx	N/A	N/A	xxx

This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2025 FactSet UK Limited. All rights reserved

Title	2019	2020	2021	2022	2023	2024
EPS Basic	xxx	xxx	xxx	xxx	xxx	-3.2
DPS All	xxx	xxx	xxx	xxx	xxx	0.0
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	563.2 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	256.0
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	49.4 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	-1.23 %

EPS Basic

Negative
Growth
Slowing

DPS All

Negative
Growth
Slowing

Sales/Revenue

Negative
Growth
Slowing

Book Value Per Share

Negative
Growth
Slowing

Net Operating Cash Flow

Negative
Growth
Slowing

Net Profit Margin

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Return on Capital Employed	xxx	xxx	xxx	xxx	xxx	-1.47 %
Return on Invested Capital	xxx	xxx	xxx	xxx	xxx	-1.46 %
Return on Assets	xxx	xxx	xxx	xxx	xxx	-1.03 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	-1.47 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	-2.50 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	47.6 M

Return on Capital Employed

Negative
Growth
Slowing

Return on Invested Capital

Negative
Growth
Slowing

Return on Assets

Negative
Growth
Slowing

Return on Equity

Negative
Growth
Slowing

Return on Total Capital

Negative
Growth
Slowing

Free Cash Flow ex dividends

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Short-Term Debt	xxx	xxx	xxx	xxx	xxx	1 M
Long Term Debt	xxx	xxx	xxx	xxx	xxx	1 M
Total Debt	xxx	xxx	xxx	xxx	xxx	1 M
Goodwill - Gross	xxx	xxx	xxx	xxx	xxx	216 M
Cash & Equivalents - Generic	xxx	xxx	xxx	xxx	xxx	257 M
Price To Book Value	xxx	xxx	xxx	xxx	xxx	8.81

Short-Term Debt

Negative
Growth
Slowing

Long Term Debt

Negative
Growth
Slowing

Total Debt

Negative
Growth
Slowing

Goodwill - Gross

Negative
Growth
Slowing

Cash & Equivalents - Generic

Negative
Growth
Slowing

Price To Book Value

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Capex	xxx	xxx	xxx	xxx	xxx	7.8 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	1.38 %
Cost of Goods Sold	xxx	xxx	xxx	xxx	xxx	140 M
Selling, General & Admin. Exp & Other	xxx	xxx	xxx	xxx	xxx	435 M
Research & Development	xxx	xxx	xxx	xxx	xxx	171 M
Investments - Total	xxx	xxx	xxx	xxx	xxx	34 M

Capex

Negative
Growth
Slowing

Capex % of Sales

Negative
Growth
Slowing

Cost of Goods Sold

Negative
Growth
Slowing

Selling, General & Admin. Exp & Other

Negative
Growth
Slowing

Research & Development

Negative
Growth
Slowing

Investments - Total

Negative
Growth
Slowing

Negative

Growth

Slowing

EXPERT VIEWS
EXTRA COVERAGE

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Bell Potter	xx/xx/xxxx	1	xxx	$xx.xx	xx.xx%	Broker commentary and detailed analysis is available for Full Members Only. Login above or Get a Free Trial
Morgan Stanley	xx/xx/xxxx	1	xxxxxxxxxx	$xx.xx	xx.xx%	Broker commentary and detailed analysis is available for Full Members Only. Login above or Get a Free Trial
Ord Minnett	03/03/2025	1	Buy	$24.88	20.08%	Ord Minnett views the Life360 4Q 2024 result was strong, with adjusted earnings (EBITDA) 24% ahead of the analyst's expectations. Management's 2025 guidance of US$465m revenue was slightly below forecasts but reflects a higher-quality revenue mix, supporting a an expected 300bp gross margin improvement. Adjusted earnings of US$70m appears achievable despite increased growth investment. The company continues to expand in the US and internationally, with European penetration still low. Advertising is in early stages, US pricing has remained unchanged for over two years, and conversion remains underutilised. Ord Minnett lifts the target price by 8% to $24.88 and retains a buy rating, citing strong long-term growth potential and structural earnings upside. FORECAST Ord Minnett forecasts a full year FY25 dividend of 0.00 cents and EPS of 10.88 cents. Ord Minnett forecasts a full year FY26 dividend of 0.00 cents and EPS of 38.16 cents.
UBS	xx/xx/xxxx	3	xxxxxxx	-	xx.xx%	Broker commentary and detailed analysis is available for Full Members Only. Login above or Get a Free Trial

Access Stockbroker Research History >

EXTRA COVERAGE

Display All Commentary

No. Of Recommendations

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Goldman Sachs	06/03/2025	1	Buy	$27.00	30.31%	Life360 posted a fourth quarter outcome that exceeded guidance and expectations. Goldman Sachs notes a step up in marketing and investment expenditure, consistent with the company's conservative approach to setting initial guidance. FY25 guidance is for revenue of US$450-480m and adjusted EBITDA of US$65-75m. The company has also reaffirmed aspirations for advertising revenue to match subscription revenue over the longer term. The broker reiterates a Buy rating and raises the target to $27 from $25. FORECAST Goldman Sachs forecasts a full year FY25 dividend of 0.00 cents and EPS of 42.91 cents. Goldman Sachs forecasts a full year FY26 EPS of 64.37 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Goldman Sachs

06/03/2025

Buy

$27.00

30.31%

Life360 posted a fourth quarter outcome that exceeded guidance and expectations. Goldman Sachs notes a step up in marketing and investment expenditure, consistent with the company's conservative approach to setting initial guidance.

FY25 guidance is for revenue of US$450-480m and adjusted EBITDA of US$65-75m. The company has also reaffirmed aspirations for advertising revenue to match subscription revenue over the longer term.

The broker reiterates a Buy rating and raises the target to $27 from $25.

FORECAST
Goldman Sachs forecasts a full year FY25 dividend of 0.00 cents and EPS of 42.91 cents.
Goldman Sachs forecasts a full year FY26 EPS of 64.37 cents.

Access Extra Coverage Research History >

360 STOCK CHART

FNArena News on 360

1	Rudi’s View: Post February Conviction Calls Mar 13 2025 - Rudi's View

2	Australian Broker Call Extra Edition – Mar 06, 2025 Mar 06 2025 - Daily Market Reports

3	FNArena Corporate Results Monitor – 03-03-2025 Mar 03 2025 - Australia

4	Rudi’s View: Best Ideas & Conviction Calls Feb 20 2025 - Rudi's View

5	Rudi’s View: Hope Trumps Uncertainties Feb 12 2025 - Rudi's View

Latest Software & Services News

1	The GenAI Arms Race Is Just Getting Started Mar 19 2025 - International

2	Pro Medicus’ Valuation Predicament Feb 19 2025 - Australia

3	DeepSeek Fuels AI Technology Advances Feb 06 2025 - Feature Stories

4	DeepSeek & More AI Excitement For 2025 Jan 28 2025 - Feature Stories

5	Xero: The Pause That Refreshes Jan 23 2025 - Technicals

6	Pro Medicus, A Global Software Super Star Dec 19 2024 - Australia

7	Higher Margins Underpin Gentrack’s Ambitions Nov 28 2024 - Small Caps

8	Targets Jump For Embattled WiseTech Nov 28 2024 - Australia

9	Nuix Rises From The Ashes Nov 08 2024 - Small Caps

10	WiseTech In Global Supply Chain Sweet Spot Oct 10 2024 - Australia

Dividend Yield Today On Last Actual Payout :	N/A
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

Get 2 Weeks free trial

Sign Up

Member Login

LIFE360 INC (360)
Share Price Analysis and Chart